72 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (“NGC”) oncology drug products. Our mission is to provide better … mission. We continue to be focused on drug products that improve the survival and/or quality of life for patients by improving the safety and/or efficacy
8-K
EX-99.1
1yka7
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
8-K
EX-99.1
uzay0ywrk
14 Dec 22
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
11:22am
8-K
EX-99.1
qqd s65fd
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.2
03y0n4620ph16khj7
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
mo158m364h4wps
4 Nov 22
Other Events
11:24am
8-K
EX-99.1
mbzgtcx my
12 Aug 22
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
10:35am
8-K
EX-99.1
c0bln2cmhai8z
4 Aug 22
Regulation FD Disclosure
9:30am
8-K
EX-99.1
qh8 1iupk8aso8208w
12 May 22
Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:21pm